Fund moves

Baxter International (BAX): Equity Investment Corp added to its stake +716K shares

Equity Investment Corp added to its stake in Baxter International, per its Q3 2025 13F.

4.66M
Shares reported · +716K vs prior quarter
2.2%
Disclosed portfolio weight
$106M
Reported value
Holdings as of
Sep 30, 2025
Filed
Nov 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 4, 2025CongressDisclosed sale of BAX — reported range $1,001 - $15,000
  2. Sep 17, 2025FDAFDA drug approval: Ketamine Hydrochloride
  3. Sep 17, 2025FDARecall: Oral Probe (Product code 02893-000), accessory used with Welch Allyn SureTemp Plus 690 (Product codes 01690-200 and 01690-400) Thermometers and Welch Allyn Sur…
  4. Sep 25, 2025CongressDisclosed purchase of BAX — reported range $1,001 - $15,000
  5. Oct 16, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 16, 2025, Heather Knight notified Baxter International Inc. (the “Company”) of her decision to resign as the Company’s Executive Vice President, Chief Operating Officer (“COO”) and interim group president of Medical Products and Therapies (“MPT”), effective as of October 29, 2025 (the “Transition Date”), to join a company in the healthcare industry.”
  6. Oct 16, 2025Court · District Court, N.D. IllinoisSecurities lawsuit filed: Electrical Workers Pension Fund, Local 103 IBEW v. Baxter International, Inc.
  7. Oct 17, 20255% stakeBlackRock Portfolio Management LLC reported a passive stake (13G) of 7.6%
  8. Oct 28, 2025FDARecall: Welch Allyn INF BAG, Thigh 1-Tube, Model/Catalog Number: REF 5089-18; Product replacement bladder for the Welch Allyn Two-Piece Blood Pressure Cuff.
  9. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
  10. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  11. Oct 31, 2025CongressDisclosed sale of BAX — reported range $1,001 - $15,000
  12. Nov 5, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 5, 2025, Alok Sonig notified Baxter International Inc. (the “Company”) of his decision to resign as the Company’s Executive Vice President and Group President, Pharmaceuticals, effective as of December 1, 2025, to join a company in the healthcare industry.”

What came next

  1. Nov 13, 20255% stakeDodge & Cox reported a passive stake (13G) of 11.2%
  2. Nov 24, 2025Government · Federal Register ruleMedicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model
  3. Nov 25, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
  4. Nov 28, 2025FDARecall: SIGMA Spectrum Infusion Pump, Model/Catalog Number: 35700BAX2
  5. Dec 3, 2025Court · District Court, N.D. IllinoisSecurities lawsuit filed: City of Hallandale Beach Police Officers' and Firefighters' Personnel Retirement Trust v. Baxter International, Inc.
  6. Dec 4, 2025Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 2 more items)
  7. Dec 16, 2025FDAFDA device clearance: Welch Allyn FlexiPort Blood Pressure Cuffs (FlexiPort Blood Pressure Cuffs)
  8. Dec 22, 2025FDARecall: Sterile Water for Irrigation, 250 mL, Single-Dose Plastic Bottle, Rx Only, Baxter Healthcare Corporation Deerfield, IL 60015 NDC: 0338-0004-02.
  9. Jan 13, 2026FDARecall: Brand Name: Spectrum IQ Product Name: Infusion Pump Model/Catalog Number: 3570009 Software Version: N/A Product Description: Infusion Pump, one unit per carton…
  10. Jan 16, 2026FDAFDA device clearance: WAVE Clinical Platform (2.0.000)
  11. Jan 21, 20265% stakePZENA INVESTMENT MANAGEMENT LLC reported a passive stake (13G) of 13.8%
  12. Jan 21, 20265% stakeBlackRock Portfolio Management LLC reported a passive stake (13G) of 8.7%
  13. Feb 5, 20265% stakeFMR LLC reported a passive stake (13G) of 6.8%
  14. Feb 10, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results (and 1 more item)“On February 10, 2026, Baxter International Inc. (the “Company”) appointed Michael R. McDonnell to its Board of Directors (the “Board”), effective February 13, 2026.”
  15. Feb 18, 2026FDARecall: Blue Ventilator Adapter Module, single-patient use circuit, Product Code M07937. Accessory to Baxter Volara Respiratory Therapy system.
  16. Feb 18, 2026FDARecall: Brand Name: Welch Allyn, Inc. Product Name: Welch Allyn Spot Vision Screener VS100 Model/Catalog Number: VS100 Software Version: Software version 3.2.0.1 Produ…
  17. Feb 26, 2026FDAFDA drug approval: Phytonadione
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Baxter International

For Baxter International, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BAX page.

How this filing works

Explore the data

Common questions

What does this filing report about Baxter International (BAX) stock?

Equity Investment Corp added to its stake in Baxter International, per its Q3 2025 13F. Now 4.66M shares, $106M reported value, 2.2% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Sep 30, 2025. Filed: Nov 5, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Baxter International recently?

For Baxter International, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BAX page.

Does this mean BAX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Baxter International

Everything OQRO holds on this company is on its BAX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data